ReviewCurrent oncology reports2023
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan.
Niraj Neupane et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it
ReviewCurrent oncology reports2023
Niraj Neupane et al.PubMed ↗Publisher ↗
No numbers read from the abstract.